These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12903850)

  • 1. Political interpretation of scientific evidence--case study of breast cancer screening policies around the world.
    Rennert G
    Recent Results Cancer Res; 2003; 163():140-8; discussion 264-6. PubMed ID: 12903850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer in Canada: to screen or not to screen?
    Taylor DW; Little E
    Int J Health Plann Manage; 1992 Jul; 7(3):171-83. PubMed ID: 10123302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Including values in evidence-based policy making for breast screening: An empirically grounded tool to assist expert decision makers.
    Parker L
    Health Policy; 2017 Jul; 121(7):793-799. PubMed ID: 28571666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening mammography in Alberta: the politics of breast health.
    Irwin ML
    Can Assoc Radiol J; 1998 Oct; 49(5):307-10. PubMed ID: 9803229
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments and response on the USPSTF recommendation on screening for breast cancer.
    Ho A
    Ann Intern Med; 2010 Apr; 152(8):542-3; author reply 543-4. PubMed ID: 20157107
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation.
    Ulloa-Pérez E; Mohar-Betancourt A; Reynoso-Noverón N
    Rev Invest Clin; 2016; 68(4):184-91. PubMed ID: 27623037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Storting debates about mammography screening in 1998].
    Solbjør M
    Tidsskr Nor Laegeforen; 2018 Jun; 138(10):. PubMed ID: 29893102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U.S. Preventive Services Task Force guidelines are not supported by the scientific evidence.
    Kopans DB
    Radiology; 2010 Oct; 257(1):294-5; author reply 295. PubMed ID: 20851947
    [No Abstract]   [Full Text] [Related]  

  • 10. Communicating evidence-based information on cancer prevention to state-level policy makers.
    Brownson RC; Dodson EA; Stamatakis KA; Casey CM; Elliott MB; Luke DA; Wintrode CG; Kreuter MW
    J Natl Cancer Inst; 2011 Feb; 103(4):306-16. PubMed ID: 21212381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening recommendations: is mammography the only answer?
    Kearney AJ; Murray M
    J Midwifery Womens Health; 2009; 54(5):393-400. PubMed ID: 19720341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening in younger women: evidence and decision making.
    Elwood JM
    J Eval Clin Pract; 1997 Aug; 3(3):179-86. PubMed ID: 9406105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US panel reaffirms controversial 2009 mammography recommendations.
    McCarthy M
    BMJ; 2015 Apr; 350():h2174. PubMed ID: 25902838
    [No Abstract]   [Full Text] [Related]  

  • 17. Position paper: breast cancer screening, diagnosis, and treatment in Denmark.
    Christiansen P; Vejborg I; Kroman N; Holten I; Garne JP; Vedsted P; Møller S; Lynge E
    Acta Oncol; 2014 Apr; 53(4):433-44. PubMed ID: 24495043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How reliable is the evidence for screening mammography?
    Feig SA
    Recent Results Cancer Res; 2003; 163():129-39; discussion 264-6. PubMed ID: 12903849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran.
    Asadzadeh VF; Broeders MJ; Kiemeney LA; Verbeek AL
    Asian Pac J Cancer Prev; 2011; 12(10):2467-75. PubMed ID: 22320940
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.